The drug will only be made available on the NHS for patients whose medical or surgical treatment for endometriosis has failed ...

UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

The combination drug could help around 1,000 women every year in England who suffer from the debilitating condition. | ITV National News ...

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

The new combination drug is known as Ryeqo and works by blocking specific hormones that contribute to the health condition ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

The study, published March 12 in JAMA Network Open, compared the newly approved tenecteplase in a single quick injection to alteplase, the stroke treatment that has been used for decades and requires ...

Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...

The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...

Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...